AYTU BIOPHARMA CEO Joshua Disbrow's 2021 pay jumps 291% to $6.2M
AYTU BIOPHARMA reports 2021 executive compensation
By ExecPay News
Published: April 7, 2022
AYTU BIOPHARMA reported fiscal year 2021 executive compensation information on April 7, 2022.
In 2021, three executives at AYTU BIOPHARMA received on average a compensation package of $2.8M, a 124% increase compared to previous year.
Average pay of disclosed executives at AYTU BIOPHARMA
Joshua R. Disbrow, Chief Executive Officer, received $6.2M in total, which increased by 291% compared to 2020. 84% of Disbrow's compensation, or $5.2M, was in stock awards. Disbrow also received $462K in bonus and $545K in salary.
David A. Green, Chief Financial Officer, received a compensation package of $1.3M, which increased by 21% compared to previous year. 39% of the compensation package, or $500K, was in other compensation.
Richard Eisenstadt, Chief Financial Officer, earned $783K in 2021.
AYTU BIOPHARMA's fiscal year ends on June 30.
Related executives
You may also like
Source: SEC filing on April 7, 2022.